HPLC Analysis and In-vitro Dissolution studies of fifteen brands of Diclofenac tablets sampled from Pharmacy stores within the Mainland area of Lagos state, Nigeria

Contenu principal de l'article

David K. Adeyemi
Oluwatosin O. Johnson
Oluwabamiwo E. Oluwaseun

Résumé

The present study aimed at analysis and in vitro dissolution studies of Diclofenac tablets sampled from Pharmacy stores within the Mainland area of Lagos state, Nigeria. Qualitative and quantitative parameters using visual inspection, uniformity of weight, uniformity of drug content and dissolution test were employed. High performance liquid chromatography (HPLC) method was used to analyze the amount of Diclofenac in the samples. Visual inspections of (fifteen different brands) individual tablets showed no visible physical deterioration, capping or breakage and all the samples were appropriately labelled and packaged. The Percentage content of the different Diclofenac tablets analysed was within 4.58% to 182.04%, where only two samples (13.33%) passed the USP specified range of 90 – 110%. The dissolution rates at pH 1.2 both with and without pepsin ranged from 4.0-10.0 %. At pH 6.8, there was a marked increase in dissolution (24%-134%) indicating the increase in drug release at higher pH. Only 2 of the six drugs assayed for dissolution with percent release of 63.81% and 71.76% complied with the official monograph specification that 56% -76% of the drug must be released at pH 6.8 in 4 hours. The results of this study indicate the need for periodic assessment of pharmaceutical products that are commercially available in the country.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Renseignements sur l'article

Comment citer
Adeyemi, D. K. ., Johnson, O. O. ., & Oluwaseun, O. E. . (2017). HPLC Analysis and In-vitro Dissolution studies of fifteen brands of Diclofenac tablets sampled from Pharmacy stores within the Mainland area of Lagos state, Nigeria. Nigerian Journal of Pharmaceutical and Applied Science Research, 6(1), 1–6. Consulté à l’adresse https://nijophasr.net/index.php/nijophasr/article/view/141
Rubrique
Articles
Bibliographies de l'auteur-e

David K. Adeyemi

Department of Pharmaceutical Chemistry, Faculty of Pharmacy. University of Lagos, Nigeria.

Oluwatosin O. Johnson

Department of Pharmaceutical Chemistry, Faculty of Pharmacy. University of Lagos, Nigeria.

Oluwabamiwo E. Oluwaseun

Department of Pharmaceutical Chemistry, Faculty of Pharmacy. University of Lagos, Nigeria

Références

Akinleye MO, Adelaja IA and Odulaja JO (2012). Comparative Evaluation of Physicochemical Properties of Some Commercially Available Brands of Metformin HCl Tablets in Lagos, Nigeria. Journal of Applied Pharmaceutical Science 02 (02):41-44.

British Pharmacopoeia, Vol. 1. The Pharmaceutical Press, Her Majesty Stationery Office, London, 2010.

Caudron JM. (2008). Substandard medicines in resource poor settings: a problem that can no longer be ignored. Tropical Medicine International Health. 13:1062-1072.

Khan MA. (2012). Studied on the effect of ph over dissolution profile of diclofenac sodium sustained release tablets. Journal of Drug Delivery & Therapeutics. 2(5): 65-66.

Kolawole JA, Olorunfemi P.O, Okeniyi SO, and Shwarpshaka, Y.J. (2002). Quality and availability of Amipicilin products (capsules and suspensions) in Nigeria. The Nigerian Journal of Pharmacy. 33: 27 –34.

Mbah CC, Emosarlu CO, Bulders PF, Isimi CY, and Kunle OO. (2012). Effect of process parameters on the properteies of some metronidazole tablets and capsule formulation. African Journal of Pharmacy and Pharmacology 6(24): 1719 -1725.

McCarberg B, and Gbofsky A. (2012). Need to develop new nonsteroidal anti-inflammatory drug formulation. Clinical Therapeutics. 34(9): 1954 -1963.

Mitrevej A, Sinchaipanid N, Rungvejhavuttivittaya Y, and Kositchaiyong V. (2001). Multiunit controlled?release diclofenac sodium capsules using complex of chitosan with sodium alginate or pectin. Pharmaceutical Development and Technology. 6(3): 385 – 392

Shah HK. (1992). Generics capture new prescription markets. Perspectives in Pharmacy Economics; 4:3

Sabnis S, Rege P, Block LH. (1997).Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. Pharmaceutical Development and Technology. 2(3): 243 – 255.

Taylor RB, O Shakoor RH, Behrens M, Everard AS. Low J, Wangboonskul RG, and Reid JA. (2001). Pharmacopoeial quality of drugs supplied by Nigeria pharmacies. The Lancet. 357, 9272: 1933 - 1936.

WHO (2012). Counterfeit medicines. Fact sheet N WHO (2006c) Technical Report Series 937. http://whqlibdoc.who.int/trs/WHO_TRS_937_eng.pdf.o 275 Revised February 2006).